SARS-CoV-2 Antibody, IgG Immune Status (Nucleocapsid & Quant. anti-Spike)

A battery of tests to determine SARS-CoV-2 immune status:

1. The Abbott Architect SARS-CoV-2 IgG assay, run under an emergency use authorization from the FDA, is a qualitative test designed to detect IgG antibodies to the nucleocapsid protein of SARS-CoV-2.
2. The Abbott Architect SARS-CoV-2 IgG II assay, run under an emergency use authorization from the FDA, is a quantitative test designed to detect IgG antibodies to the spike protein of SARS-CoV-2 in serum and plasma. Results are reported as AU/mL. Per manufacture’s package insert protective level is ≥50.0 AU/mL.

For ordering individual battery components:

NCVIGG see SARS CoV 2 Nucleocapsid Antibody, IgG [NCVIGG]

NVCIGQ see SARS CoV 2 Spike Antibody, IgG [NCVIGQ]

For all questions, contact Client Support Services (available 24/7):

Phone: (206) 520-4600 or (800) 713-5198
Fax: (206) 520-4903
Email: commserv@uw.edu

The test order requisition is available online

Spin within 24 hours and prior to shipment.
sample is stable for 7 days at 2-8°C once separated from a clot or red blood cells, or in a gel separator tube.
If testing will be delayed more than 7 days store at -20°C or colder.

UW Medicine
Department of Laboratory Medicine
Virology- Covid Testing Lab
1602 Raymond Ave SW
Renton, WA 98057-3356
Tel: (206) 685-6656 opt 4

Centrifuge GOLD SST tube and route to Virology Central Lab (Renton)..

Centrifuge RED TOP or EDTA tube and aliquot serum/plasma into plastic aliquot tube. Route to Virology Central Lab (Renton).

Stability: Sample stable off the clot, red blood cells, or separator gel for 7 days at 2-8°C. If testing will be delayed more than 7 days store at -20°C or colder.